Similar articles

• Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.

  Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, Toovey S, Knobloch J, Nothdurft HD, Shaw D, Roskell NS, Chulay JD; Malarone International Study Team. Overbosch D, et al. Clin Infect Dis. 2001 Oct 1;33(7):1015-21. doi: 10.1086/322694. Epub 2001 Sep 5. Clin Infect Dis. 2001. PMID: 11528574 Clinical Trial.
• Chemoprophylaxis according to the guidelines on malaria prevention for Japanese overseas travelers.

  Mizuno Y, Kudo K, Kano S. Mizuno Y, et al. Southeast Asian J Trop Med Public Health. 2006;37 Suppl 3:11-4. Southeast Asian J Trop Med Public Health. 2006. PMID: 17547042
• Prophylaxis against malaria. More studies of mefloquine prophylaxis must be done in tourists.

  Croft AM, Whitehouse DP. Croft AM, et al. BMJ. 1999 Apr 24;318(7191):1139-40. BMJ. 1999. PMID: 10366265 No abstract available.
• Clinical practice. Malaria prevention in short-term travelers.

  Freedman DO. Freedman DO. N Engl J Med. 2008 Aug 7;359(6):603-12. doi: 10.1056/NEJMcp0803572. N Engl J Med. 2008. PMID: 18687641 Review. No abstract available.
• Mefloquine to prevent malaria: a systematic review of trials.

  Croft A, Garner P. Croft A, et al. BMJ. 1997 Nov 29;315(7120):1412-6. doi: 10.1136/bmj.315.7120.1412. BMJ. 1997. PMID: 9418088 Free PMC article.